title: Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experience.
authors: Laboratory of Chemical Biology, NIDDK, Bethesda, Maryland 20892.
authors: G P
authors: GP
authors: Rodgers
authors: G J
authors: GJ
authors: Dover
authors: C T
authors: CT
authors: Noguchi
authors: A N
authors: AN
authors: Schechter
authors: A W
authors: AW
authors: Nienhuis
mesh_terms: D000328:Adult; D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004906:Erythrocyte Count / Q000187:drug effects; D005260:Female; D005319:Fetal Hemoglobin / Q000096:biosynthesis* / Q000187:drug effects; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D009316:National Institutes of Health (U.S.); D012156:Reticulocytes / Q000187:drug effects; D014481:United States
chemical_list: D005319:Fetal Hemoglobin; D006918:Hydroxyurea